Jun'05 | Jun'06 | Jun'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Jun'12 | Jun'13 | Jun'14 | Jun'15 | Jun'16 | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 15.5% | 14.6% | 7.9% | 11.0% | 13.3% | 15.8% | 15.0% | 15.3% | 19.1% | 20.5% | 21.1% | 21.5% | 18.7% | 15.7% | 19.6% | 27.2% | 17.6% | 25.0% | 24.0% | 22.7% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 23.9%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Return on Equity (ROE) for ResMed Inc. have been 21.3% over the past three years, and 22.9% over the past five years.
As of today, ResMed Inc.'s Return on Equity (ROE) is 23.9%, which is higher than industry median of (3.2%). It indicates that ResMed Inc.'s Return on Equity (ROE) is Good.